Sam Eiber
Stock Analyst at BTIG
(3.32)
# 2,479
Out of 4,587 analysts
57
Total ratings
52.9%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Sam Eiber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMSI Merit Medical Systems | Reiterated: Buy | $100 → $105 | $83.35 | +25.97% | 6 | Jul 31, 2026 | |
| STIM Neuronetics | Initiated Coverage: Buy | $5 | $1.97 | +153.81% | 1 | Jul 20, 2026 | |
| BWAY BrainsWay | Initiated Coverage: Buy | $18 | $15.25 | +18.03% | 1 | Jul 20, 2026 | |
| ESTA Establishment Labs Holdings | Maintained: Buy | $90 → $96 | $93.48 | +2.70% | 12 | Jul 13, 2026 | |
| EOLS Evolus | Maintained: Buy | $13 | $6.01 | +116.31% | 12 | Jul 10, 2026 | |
| INMD InMode | Rated: Hold | n/a | $15.10 | - | 10 | Jul 10, 2026 | |
| ICUI ICU Medical | Initiated Coverage: Buy | $170 | $168.38 | +0.96% | 1 | Jun 15, 2026 | |
| AIRS AirSculpt Technologies | Maintained: Hold | n/a | $4.85 | - | 5 | May 18, 2026 | |
| SBC SBC Medical Group Holdings | Maintained: Buy | $8 | $3.04 | +163.16% | 2 | May 14, 2026 | |
| APYX Apyx Medical | Upgraded: Buy | $6 | $4.12 | +45.63% | 7 | Mar 11, 2026 |
Merit Medical Systems
Jul 31, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $83.35
Upside: +25.97%
Neuronetics
Jul 20, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.97
Upside: +153.81%
BrainsWay
Jul 20, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $15.25
Upside: +18.03%
Establishment Labs Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $90 → $96
Current: $93.48
Upside: +2.70%
Evolus
Jul 10, 2026
Maintained: Buy
Price Target: $13
Current: $6.01
Upside: +116.31%
InMode
Jul 10, 2026
Rated: Hold
Price Target: n/a
Current: $15.10
Upside: -
ICU Medical
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $170
Current: $168.38
Upside: +0.96%
AirSculpt Technologies
May 18, 2026
Maintained: Hold
Price Target: n/a
Current: $4.85
Upside: -
SBC Medical Group Holdings
May 14, 2026
Maintained: Buy
Price Target: $8
Current: $3.04
Upside: +163.16%
Apyx Medical
Mar 11, 2026
Upgraded: Buy
Price Target: $6
Current: $4.12
Upside: +45.63%